SRPT vs UPBD · rev $1.90B vs P/E 12, rev $4.32B
Sarepta Therapeutics Inc (SRPT) versus Upbound Group Inc. (UPBD) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Upbound Group Inc. (UPBD) is a software - application company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported UPBD revenue for 2024-12-31 was $4.32B. Net income was $123.5M. Revenue was up 8.2% from 2023-12-31 to 2024-12-31. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
SRPT currently screens at market cap $2.34B. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
Not investment advice. Open the SRPT and UPBD stock pages for the full models.
Not investment advice.